期刊文献+

恶性疟原虫现场样品HRP-Ⅱ基因部分序列分析 被引量:1

ANALYSIS ON THE POLYMORPHISM OF PLASMODIUM FALCIPARUM HRP-Ⅱ GENE
下载PDF
导出
摘要 目的 分析和比较不同地理株恶性疟原虫现场样品及我国恶性疟原虫现场样品与实验室培养虫株在HRP Ⅱ基因上的多态性。 方法 分别以在中国感染的恶性疟病人和在非洲感染的恶性疟病人全血为材料 ,PCR扩增HRP Ⅱ基因片段 ,扩增的产物分别克隆于 pUCm T载体并进行测序 ,用GENEDOC软件比较分析核苷酸序列及其推导的氨基酸序列的同源性。 结果 从中国海南省和云南省恶性疟病人血样中扩增出序列和长度完全相同的片段 ,大小为44 7bp ;从在非洲感染的恶性疟病人血样中扩增出 813bp的片段 ;中国恶性疟原虫实验室培养株相应核苷酸序列长度为870bp。从中国恶性疟病人血样扩增出的HRP Ⅱ基因片段序列与从非洲恶性疟病人血样扩增出的HRP Ⅱ基因片段序列及我国恶性疟原虫培养株相应的核苷酸序列相比 ,不但有多个长短不等序列的缺失和插入 ,还有多个碱基发生了突变 ;比较推导的氨基酸序列 ,除了有多个长短不等氨基酸序列的缺失和插入外 ,其他氨基酸残基没有发生改变。 结论 恶性疟原虫HRP Ⅱ基因在不同地理株间存在差异 ,在同一地理株的实验室培养株与现场样品间也存在差异 。 Objective To analyze the polymorphism of Plasmodium falciparum HRP-Ⅱ gene in field samples with different geographic origin or between field strains and cultured isolate. Methods HRP- Ⅱ gene fragments of P. falciparum were amplified by PCR from blood samples of patients infected with P. falciparum in China and in Africa, respectively, then the amplified fragments were cloned into vector pUCm-T and their nucleotide sequences were determined. The sequences were compared and analyzed using GENEDOC software. Results A fragment of 447 bp was amplified from all blood samples from patients infected with P. falciparum in China and their sequences were also identical. However, a 813 bp fragment was amplified from blood samples of patients infected with P. falciparum in Africa. Alignment of their sequences revealed that not only different length of sequences were deleted and a eighteen-oligonucleotide was inserted in the HRP-Ⅱ gene fragment amplified from blood of patients infected in China, but also ten nucleotides were different between two amplified nucleotide sequences. There was no difference in the two deduced amino acid sequences except a few deletions and/or insertions of different length. Alignment of sequence from Chinese falciparum malaria patients with published sequence from cultured Chinese strain of P. falciparum also revealed deletion/insertion of several different length of sequences and several nucleotide mutation. Conclusion There was considerable difference in the HRP-II gene, mainly in length of sequence, not only in field strains with different geographic origin but also between field samples and cultured strain of P. falciparum.
出处 《中国寄生虫病防治杂志》 CSCD 2004年第5期257-260,共4页 Chinese Journal of Parasitic Disease Control
基金 科技部科研院所技术开发研究专项资金资助项目(No .2 0 0 3 - 2 0 0 5)
关键词 疟原虫 恶性 HRP-基因 多态性 Plasmodium falciparum histidine-rich protein Ⅱ polymorphism
  • 相关文献

参考文献9

  • 1方建民,余新炳,罗树红,徐劲.恶性疟原虫组氨酸富集蛋白II基因克隆及测序[J].中国寄生虫学与寄生虫病杂志,1999,17(5):277-281. 被引量:5
  • 2Viriyakosol S, Siripoon N, Zhu XP, et al. Plasmodium falciparum: selective growth of subpopulations from field samples following in vitro culture, as detected by the polymerase chain reaction[J].Exp Parasitol,1994,79: 517-525.
  • 3Snewin VA, Herrera M, Sanchez G, et al. Polymorphism of the alleles of the merozoite surface antigens MAS1 and MAS2 in Plasmodium falciparum wild isolate from Colombia[J]. Mol Biochem Parasitol,1991,49:265-275.
  • 4Anthony Moody. Rapid diagnostic tests for malaria parasites[J].Clinical Microbiology Reviews,2002,15(1):66-78.
  • 5Enders B, Hundt E, Knapp B. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum[J]. Mem Inst Oswaldo Cruz,1992,87(suppl 3):413-424.
  • 6John E. Protocols in molecular parasitology[M]. Humana Press Inc.,1993.205-211.
  • 7Kimura M, Kaneko S, Inoue A, et al. Amplification by polymerase chain reaction of Plasmodium falciparum DNA from giemsa-stained thin blood smears[J]. Mol Biochem Parasitol,1995,70:193-197.
  • 8Bernhard K, Uwe N, Erika H. Conservation of antigen components from two recombinant hybrid proteins protective against malaria[J].Infection and Immunity,1993,61:892-897.
  • 9J萨姆布鲁克 E.F.弗里奇 T.曼尼阿蒂斯.分子克隆实验指南[M](第2版)[M].北京:科学出版社,1995.10-18.

二级参考文献2

共引文献7

同被引文献32

  • 1World Health Organization. World malaria report 2012 [R]. Gene- va: WHO, 2012: 1-195.
  • 2Talisuna A, Adibaku S, Dorsey G, et al. Malaria in Uganda: chal- lenges to control on the long road to elimination. II. the path for- ward[J]. Acta Trop, 2012, 12(1): 196-201.
  • 3White NJ, Pukrittayakamee S, Hien TY, et al. Malaria[J]. Laneet, 2013, 38(3): 723-735.
  • 4World Health Organization. Guidelines for the treatment of malar- ias[S]. Geneva: WHO, 2010, 2: 1-194.
  • 5Shin HI, Kim JY, Lee WJ, et al. Polymorphism of the parasite lactate dehydrogenase gene from Plasmodium vivax Korean iso- lates[J]. Malar J, 2013, 12: 166.
  • 6Kim JY, Kim HH, Shin HL, et al. Genetic variation of aldolase from Korean isolates of Plasmodium vivax and its usefulness in serodiagnosis[J]. Malar J, 2012, 11: 159.
  • 7Ly AB, Tall A, Perry R, et al. Use of HRP-2-based rapid diag- nostic test for Plasmodiumfolciparum malaria: assessing accuracy and cost effectiveness in the villages of Dielmo and Ndiop, Sene- gal[J]. Malar J, 2010, 9: 153.
  • 8Nkrumah B, Acquah SE, Ibrahim L, et al. Comparative evalua-tion of two rapid field tests for malaria diagnosis: partec rapid malaria test(R) and binax Now(R) malaria rapid diagnostic test[J]. BMC Infect Dis, 2011, 23(11): 143.
  • 9World Health Organization (WHO). Malaria rapid diagnostic test performance: result of WHO product testing of malaria RDTs Round 3 (2010-2011 ) [R ].Geneva: WHO, 2011: 1-82.
  • 10Hendriksen IC, Mwanga-Amumpaire J, yon Seidlein L ,et al. Di- agnosing severe falciparum malaria in parasitaemic African chil- dren: a prospective evaluation of plasma PfHRP2 measurement [J]. PLoS Med, 2012, 9(8): e1001297, http://www.plosmedicine.org/ article/info%3Adoi%2F 10.1371%2Fjournal.pmed. 1001297.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部